Diclofenac Amide-13C6
Diclofenac Amide-13C6 is the 13C-labeled Diclofenac amide (HY-134521). Diclofenac amide is an orally active prodrug of Diclofenac (HY-15036). Diclofenac amide undergoes biotransformation in vivo. Diclofenac amide reduces COX-2 protein expression. Diclofenac amide inhibits Carrageenan (HY-125474)-induced PGE2 release in peritoneal lavage fluid. Diclofenac amide inhibits Carrageenan-induced paw edema. Diclofenac amide can be used for inflammation research.
For research use only. We do not sell to patients.
- Formula: C813C6H9Cl2NO
- Molecular Weight:284.09
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
IC50 & Target
[1]|
COX-2 |
Application
1. This compound can be used as a tracer
2. This compound can be used as an internal standard for quantitative analysis by NMR, GC-MS, or LC-MS.
Chemical Information
-
Unlabeled CAS 15362-40-0
-
Molecular Weight 284.09
-
Formula C813C6H9Cl2NO
-
SMILES
O=C1C[13C]2=[13C]([13C]([H])=[13C]([13C]([H])=[13C]2N1C3=C(C=CC=C3Cl)Cl)[H])[H]
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Keywords
- Diclofenac Amide-13C6
- Isotope-Labeled Compounds
- Drug Intermediate
- COX
- PGE synthase
- Drug Iintermediate
- Cyclooxygenase
- Prostaglandin E synthase
- COX-2 inhibitor
- PGE2
- carrageenan
- gastric lesions
- inflammation
- leukocyte accumulation
- neutrophil accumulation
- paw edema
- pharmaceutical contaminant
- prodrug
- Inhibitor
- inhibitor
- inhibit